September 17, 2015 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) recently cleared the ...
A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the potential of providing physicians with information that could save the lives of patients with ischemic stroke or pulmonary embolism. Both conditions are caused when important blood vessels are blocked by a clot that has traveled from another part of the body. In a report that will appear in the October issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology and has been published online, the MGH team describes using this new probe to conduct full-body scans in an animal model. Preliminary results also were reported earlier this year at the national meeting of the American Chemical Society.
RedRick Technologies recently released the first planning guide focused on medical imaging reading environment optimization. The project was a collaboration with CannonDesign, an integrated global design firm.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
3-D tomosynthesis is the latest technology to provide clearer images during screening and diagnostic procedures; however, it has not always been widely available. Hologic was the only vendor with U.S. Food and Drug Administration (FDA) approval until April of this year, when Siemens received the much-awaited green light to sell their product in the United States. In the KLAS report Women's Imaging 2015: Are New Technologies Delivering Promised Benefits?, data shows Hologic is still dominating the 3-D tomosynthesis marketplace but is facing competition from Siemens and GE. Now approved, Siemens did not waste any time upgrading their systems, and providers are responding positively. GE is not receiving the same response from users because their 3-D system is lagging due to implementation delays.
Mach7 Technologies announced the release of its latest version of Mach7 Enterprise Imaging Platform. The updated version 11.7 includes several enhancements and introduces new functionality to improve end-user satisfaction and simplify image management, access, and sharing across healthcare organizations.
![](/sites/default/files/styles/content_feed_medium/public/FCT%20iStream%203qtr%20with%20Tech%20RGB_1.png?itok=M9tQB8sN)
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
With the increased availability of and reliance on high-dose imaging modalities for rapid and comprehensive diagnosis ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Montage Healthcare Solutions Inc. announced this week the latest software release for Montage Search and Analytics, designed for radiology practices striving to enhance their operations. Building on a robust follow-up tracking capability, Montage's new Follow-Up QC module enables departments to monitor, analyze and optimize follow-up recommendations made by radiologists. Also featured in this new release are several user interface enhancements, numerous new analytic tools, and new quality control (QC) and search features.
Hitachi Ltd. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for commercial supply of the new Probeat-V system designed and developed for Mayo Clinic in Rochester, Minnesota. Treatments began in late June and the first patient treatment was completed in August 2015.
The Susan G. Komen Illinois Affiliates applaud Rep. Mike Smiddy (D-Hillsdale) on the passage of the Breast Cancer Excellence in Survival and Treatment Act (BEST Act, HB3673) into law.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
September 15, 2015 — Imaging patients soon after a traumatic brain injury (TBI) can lead to more accurate detection of ...
More than one in three computed tomography (CT) sites surveyed by The Association for Medical Imaging Management (AHRA) ...
The current state of proton therapy can be assessed fairly quickly by looking at a map: At the end of 2014, there were ...
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
Vital Images Inc. recently introduced the VioSuite Image Management and Vitality Solutions Business Intelligence product families, providing healthcare administrators with a robust set of tools to improve system-wide image access and image data analytics. VioSuite and Vitality Solutions, as well as the company’s flagship products VitreaAdvanced and VitreaView software, were showcased at the 9th annual Health Information and Management Systems Society (HIMSS) Asia Pacific Conference and Exhibition.
September 14, 2015 — A new decision rule will help emergency department physicians determine when to use radiography in ...
![This latest version of Ensight expands the suite of available use cases and provides additional capabilities.](/sites/default/files/styles/content_feed_medium/public/Series%20Impacted%20by%20Endex.png?itok=9v56GnsU)
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Eizo announced it is now offering a white cabinet option for three FlexScan monitors with ultra-slim bezels.
ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's proprietary imaging agent for management of prostate cancer. IAB2M demonstrated superior performance in detecting disease compared with ProstaScint and conventional imaging technologies including computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and bone scans. In addition, the agent accurately detected metastatic disease in normal-sized lymph nodes, overcoming a major limitation of existing technologies and addressing a key clinical need.
The widespread practice of incentivizing mammogram completion via cash payments, typically by insurance companies, is unethical according to a Viewpoint article published recently in JAMA by an expert from the Perelman School of Medicine at the University of Pennsylvania. Instead, incentives should be offered to women to use evidence-based decision aids to decide if they want a mammogram, even if this policy likely averts fewer breast cancer deaths overall.
September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., was ...
The use of radiation therapy to treat cancer has been in existence for over a century, tracing back to the early days of ...
Navigating coverage decisions can be overwhelming and confusing, especially for high-end imaging equipment, where ...